THE PENNANT GROUP, INC. Costs and Expenses
THE PENNANT GROUP, INC. (PNTG) reported Costs and Expenses of $280.80 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2026-08-05
- THE PENNANT GROUP, INC. costs and expenses for the quarter ending 2026-06-30 was $280.80M, a 35.02% increase year-over-year.
- THE PENNANT GROUP, INC. costs and expenses for the quarter ending 2026-03-31 was $268.06M, a 35.94% increase year-over-year.
- THE PENNANT GROUP, INC. costs and expenses for the quarter ending 2025-12-31 was $271.85M, a 51.32% increase year-over-year.
- THE PENNANT GROUP, INC. costs and expenses for the quarter ending 2025-09-30 was $218.80M, a 28.79% increase year-over-year.
- THE PENNANT GROUP, INC. costs and expenses for fiscal 2025 was $895.82M, a 36.32% increase from fiscal 2024.
- THE PENNANT GROUP, INC. costs and expenses for fiscal 2024 was $657.12M, a 26.44% increase from fiscal 2023.
- THE PENNANT GROUP, INC. costs and expenses for fiscal 2023 was $519.72M, a 12.86% increase from fiscal 2022.
- THE PENNANT GROUP, INC. costs and expenses for fiscal 2022 was $460.50M, a 5.86% increase from fiscal 2021.
| Period end | Costs and Expenses 3 month | Costs and Expenses 6 month | Costs and Expenses 9 month | Costs and Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $280.80M 10-Q · filed 2026-08-05 | $548.86M 10-Q · filed 2026-08-05 | $820.71M derived: sum of 3 quarters · filed 2026-08-05 | $1.04B derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $268.06M 10-Q · filed 2026-05-06 | $539.92M derived: sum of 2 quarters · filed 2026-05-06 | $758.72M derived: sum of 3 quarters · filed 2026-05-06 | $966.69M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $271.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $490.65M derived: sum of 2 quarters · filed 2026-02-26 | $698.63M derived: sum of 3 quarters · filed 2026-08-05 | $895.82M 10-K · filed 2026-02-26 |
| 2025-09-30 | $218.80M 10-Q · filed 2025-11-05 | $426.77M derived: sum of 2 quarters · filed 2026-08-05 | $623.97M 10-Q · filed 2025-11-05 | $803.62M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $207.97M 10-Q · filed 2026-08-05 | $405.17M 10-Q · filed 2026-08-05 | $584.82M derived: sum of 3 quarters · filed 2026-08-05 | $754.72M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $197.19M 10-Q · filed 2026-05-06 | $376.85M derived: sum of 2 quarters · filed 2026-05-06 | $546.74M derived: sum of 3 quarters · filed 2026-05-06 | $705.92M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $179.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $349.55M derived: sum of 2 quarters · filed 2026-02-26 | $508.73M derived: sum of 3 quarters · filed 2026-02-26 | $657.12M 10-K · filed 2026-02-26 |
| 2024-09-30 | $169.89M 10-Q · filed 2025-11-05 | $329.08M derived: sum of 2 quarters · filed 2025-11-05 | $477.47M 10-Q · filed 2025-11-05 | $615.86M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $159.18M 10-Q · filed 2025-08-06 | $307.57M 10-Q · filed 2025-08-06 | $445.96M derived: sum of 3 quarters · filed 2026-02-26 | $579.09M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $148.39M 10-Q · filed 2025-05-06 | $286.78M derived: sum of 2 quarters · filed 2026-02-26 | $419.91M derived: sum of 3 quarters · filed 2026-02-26 | $545.93M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $138.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $271.52M derived: sum of 2 quarters · filed 2026-02-26 | $397.54M derived: sum of 3 quarters · filed 2026-02-26 | $519.72M 10-K · filed 2026-02-26 |
| 2023-09-30 | $133.13M 10-Q · filed 2024-11-06 | $259.15M derived: sum of 2 quarters · filed 2024-11-06 | $381.33M 10-Q · filed 2024-11-06 | $499.62M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $126.02M 10-Q · filed 2024-08-06 | $248.20M 10-Q · filed 2024-08-06 | $366.49M derived: sum of 3 quarters · filed 2025-02-27 | $477.69M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $122.18M 10-Q · filed 2024-05-06 | $240.47M derived: sum of 2 quarters · filed 2025-02-27 | $351.67M derived: sum of 3 quarters · filed 2025-02-27 | $471.10M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $118.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $229.49M derived: sum of 2 quarters · filed 2025-02-27 | $348.92M derived: sum of 3 quarters · filed 2025-02-27 | $460.50M 10-K · filed 2025-02-27 |
| 2022-09-30 | $111.21M 10-Q · filed 2023-11-07 | $230.64M derived: sum of 2 quarters · filed 2023-11-07 | $342.22M 10-Q · filed 2023-11-07 | $456.18M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $119.43M 10-Q · filed 2023-08-08 | $231.01M 10-Q · filed 2023-08-08 | $344.97M derived: sum of 3 quarters · filed 2024-02-28 | $455.19M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $111.58M 10-Q · filed 2023-05-04 | $225.54M derived: sum of 2 quarters · filed 2024-02-28 | $335.76M derived: sum of 3 quarters · filed 2024-02-28 | $442.53M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $113.95M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $224.17M derived: sum of 2 quarters · filed 2024-02-28 | $330.95M derived: sum of 3 quarters · filed 2024-02-28 | $435.00M 10-K · filed 2024-02-28 |
| 2021-09-30 | $110.22M 10-Q · filed 2022-11-07 | $217.00M derived: sum of 2 quarters · filed 2022-11-07 | $321.05M 10-Q · filed 2022-11-07 | $424.92M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $106.78M 10-Q · filed 2022-08-08 | $210.83M 10-Q · filed 2022-08-08 | $314.70M derived: sum of 3 quarters · filed 2023-02-23 | $408.62M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $104.05M 10-Q · filed 2022-05-09 | $207.93M derived: sum of 2 quarters · filed 2023-02-23 | $301.84M derived: sum of 3 quarters · filed 2023-02-23 | $388.51M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $103.88M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $197.79M derived: sum of 2 quarters · filed 2023-02-23 | $284.46M derived: sum of 3 quarters · filed 2023-02-23 | $372.04M 10-K · filed 2023-02-23 |
| 2020-09-30 | $93.92M 10-Q · filed 2021-11-08 | $180.58M derived: sum of 2 quarters · filed 2021-11-08 | $268.16M 10-Q · filed 2021-11-08 | $359.05M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $86.67M 10-Q · filed 2021-08-09 | $174.24M 10-Q · filed 2021-08-09 | $265.13M derived: sum of 3 quarters · filed 2022-02-28 | $351.60M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $87.58M 10-Q · filed 2021-05-06 | $178.46M derived: sum of 2 quarters · filed 2022-02-28 | $264.94M derived: sum of 3 quarters · filed 2022-02-28 | $344.36M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $90.89M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $177.36M derived: sum of 2 quarters · filed 2022-02-28 | $256.78M derived: sum of 3 quarters · filed 2022-02-28 | $332.86M 10-K · filed 2022-02-28 |
| 2019-09-30 | $86.47M 10-Q · filed 2020-11-10 | $165.89M derived: sum of 2 quarters · filed 2020-11-10 | $241.97M 10-Q · filed 2020-11-10 | $312.60M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $79.42M 10-Q · filed 2020-08-11 | $155.50M 10-Q · filed 2020-08-11 | $226.12M derived: sum of 3 quarters · filed 2021-02-24 | $293.27M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $76.08M 10-Q · filed 2020-05-13 | $146.70M derived: sum of 2 quarters · filed 2021-02-24 | $213.85M derived: sum of 3 quarters · filed 2021-02-24 | |
| 2018-12-31 | $70.62M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $137.77M derived: sum of 2 quarters · filed 2021-02-24 | $265.43M 10-K · filed 2021-02-24 | |
| 2018-09-30 | $67.15M 10-Q · filed 2019-11-12 | $194.81M 10-Q · filed 2019-11-12 | ||
| 2017-12-31 | $235.59M 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |